ACL/PCL Reconstruction Devices Market Size, Share, and Industry Analysis, By Product Type (Graft Fixation Devices, Graft Preparation & Passage Instruments, and Artificial Ligaments), By Procedure Type (Anterior Cruciate Ligament (ACL) Reconstruction, Posterior Cruciate Ligament (PCL) Reconstruction, and Multi-ligament Knee Reconstruction), By End-user (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast till 2034

The ACL/PCL reconstruction devices market size was valued at USD 6.20 billion in 2025 and is expected to reach a market valuation of USD 6.51 billion in 2026. Furthermore, the market is projected to reach a market valuation of USD 9.65 billion by 2034, exhibiting a CAGR of 5.0% during the forecast period.

There have been significant technological advancements in minimally invasive arthroscopic surgery and fixation devices, which have improved surgical precision and patient outcomes, accelerating market growth.

ACL/PCL Reconstruction Devices Market Driver

Rising Sports Participation and Injury Incidence to Drive the Market Growth

Over the past few years, increasing participation in professional and recreational sports, particularly high-impact activities such as basketball, skiing, and soccer, has significantly driven ACL and PCL injury rates globally. This is increasing the need for surgical intervention, driving the demand for devices, and fueling the market expansion.

• For instance, the National ACL Injury Coalition analyzed injury data from 12 major girls' and boys' sports across five three-year periods (2007-2022), sourced from certified athletic trainers in the High School RIO surveillance program. Between the first and fifth periods, the average annual ACL injury rate increased by 25.9% to 7.3 per 100,000 athlete exposures, accounting for over 14% of all knee injuries.

Download Free sample to learn more about this report.

According to data published by the Biocomposites in February 2025, in the U.S., around 30.0 million children and adolescents engage in youth sports annually. High school athletes sustain roughly 2.0 million injuries yearly, leading to 500,000 doctor visits and 30,000 hospitalizations.

ACL/PCL Reconstruction Devices Market Restraint

High Procedure and Implant Costs to Hamper the Market Growth

Although ACL/PCL reconstruction procedures are highly necessary, they involve premium fixation devices, arthroscopic instrumentation, surgical facility charges, and rehabilitation costs, making them expensive in many healthcare facilities. Also, limited reimbursements in some countries may lead surgeons to opt for lower-cost alternatives, further restricting premium product penetration and hampering the market growth.

• For instance, according to the Burnham Sports Medicine Institute, the total cost of the procedure typically ranges from USD 20,000 to USD 50,000. This includes the surgeon's fee of USD 500-1,000, the anesthesia fee of USD 1,000-2,500, and facility charges of USD 15,000-40,000.

ACL/PCL Reconstruction Devices Market Opportunity

Development of Biologic and Hybrid Fixation Systems to Offer Lucrative Growth Opportunity

In recent years, there has been an increasing innovation in biologic-enhanced graft fixation, including bio-integrative materials and growth-factor-coated implants. Also, key players are exploring hybrid devices combining mechanical strength with biological stimulation to enhance healing and reduce failure rates. This is expected to offer significant opportunities for reconstruction devices, particularly in revision surgeries and high-performance athletes.

Segmentation

Key Insights

The report covers the following key insights:

• Number of Key Procedures, by Key Countries/Region, 2025
• Overview of Reimbursement Scenario
• Key Industry Developments - (Partnerships, Mergers, and Acquisitions, etc.)

Analysis by Product Type

By product type, the market is segmented into graft fixation devices, graft preparation & passage instruments, and artificial ligaments.

The graft fixation devices segment is expected to hold the major share of the global market during the forecast period. The segment’s growth is driven by the widespread use of interference screws, cortical buttons, cross pins, and staples in nearly every ACL and PCL reconstruction procedure, as these procedures require multiple fixation implants.

Analysis by Procedure Type

By procedure type, the market is segmented into anterior cruciate ligament (ACL) reconstruction, posterior cruciate ligament (PCL) reconstruction, and multi-ligament knee reconstruction.

The anterior cruciate ligament (ACL) reconstruction segment is expected to hold the major share of the global market during the forecast period. ACL injuries are far more common than PCL injuries, as they often occur during sports that involve pivoting and sudden directional changes, which contribute to the segment’s growth.

Analysis by End-user

Based on end-user, the market is divided into hospitals & ASCs, specialty clinics, and others.

The hospitals & ASCs segment is expected to hold the largest share of the global market during the forecast period. The segment’s growth is attributed to the large number of orthopedic surgeons and hospitals in developed markets, which is anticipated to favor the adoption of ACL/PCL reconstruction devices.

• For instance, according to the data from the International Society for the Advancement of Spine Surgery (ISASS) in August 2022, around 23,000 orthopedic surgeons were practicing in the U.S.

Regional Analysis

Request for Customization   to gain extensive market insights.

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for a 40.8% share of the global ACL/PCL reconstruction devices market in 2025. A well-established ambulatory surgical center (ASC) network and strong sport participations is expected to surge in the ACL reconstructions volumes, leading to higher adoption of premium fixation systems such as adjustable-loop cortical buttons and biocomposite screws

• For instance, in February 2026, according to data from Biocomposites, over 200,000 ACL injuries occurred, with about half requiring knee reconstruction surgery in the U.S.

Asia Pacific is expected to grow at the highest CAGR during the forecast period. Growing healthcare investment and expanding insurance coverage are enabling access to advanced arthroscopic procedures, including ACL/PCL reconstruction, which is expected to increase the use of ACL/PCL reconstruction devices, driving the region’s growth.

Key Players Covered

The global ACL/PCL reconstruction devices market is highly competitive, with leading companies focusing on new product introductions, strategic geographic expansion, and other growth initiatives to strengthen their market positions.

The report includes the profiles of the following key players:

• Arthrex, Inc. (U.S.)
• Smith+Nephew (U.K.)
• Stryker (U.S.)
• Zimmer Biomet (U.S.)
• DePuy Synthes (U.S.)
• CONMED Corporation (U.S.)
• Medtronic (Ireland)
• Olympus Corporation (Japan)
• Mathys AG Bettlach (Switzerland)
• Corin Group (U.K.)

Key Industry Developments

• March 2025: Miach Orthopaedics received FDA 510(k) clearance to expand its BEAR Implant indications to children and adolescents of any age, plus partial ACL tears.
• January 2023: Arthrex, Inc. received FDA clearance for the ACL TightRope II implant, the first device specifically designed for ACL reconstruction in children and adolescents with open growth plates.